MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-14-2026
QIAGEN N.V. Operating Cash Flow 2011-2026 | QGEN
Annual Operating Cash Flow QIAGEN N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 674 M | 459 M | 715 M | 639 M | 458 M | 331 M | 359 M | 287 M | 342 M | 317 M | 288 M | 259 M | 245 M | 245 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 715 M | 245 M | 401 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.48 B | $ 110.24 | -2.86 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Waters Corporation
WAT
|
653 M | $ 289.16 | -3.79 % | $ 17.2 B | USA |
 |
Exagen
XGN
|
-13.6 M | $ 2.68 | -3.94 % | $ 57.8 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.36 | -11.57 % | $ 176 M |  China |
 |
Sotera Health Company
SHC
|
287 M | $ 13.13 | -3.03 % | $ 3.73 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
BioNano Genomics
BNGO
|
-16.3 M | $ 1.16 | 0.87 % | $ 6.32 M | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
1.44 B | $ 62.25 | -5.81 % | $ 24.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 23.53 | -4.74 % | $ 654 M | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 159.16 | -3.62 % | $ 7.89 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 195.51 | -1.33 % | $ 21.7 B | USA |
 |
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
PerkinElmer
PKI
|
583 M | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
4.65 M | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 8.7 | -4.92 % | $ 1.89 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 264.2 | -1.56 % | $ 22 B | USA |
 |
Psychemedics Corporation
PMD
|
-1.48 M | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-3.56 M | $ 25.97 | -4.52 % | $ 33.7 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 16.78 | -3.95 % | $ 894 M | USA |
 |
Quotient Limited
QTNT
|
-77.6 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
450 M | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
-30.1 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
VolitionRx Limited
VNRX
|
-25.9 M | $ 0.2 | 1.87 % | $ 19.2 M |  Singapore |
 |
Bioventus
BVS
|
74.7 M | $ 8.94 | -3.46 % | $ 596 M | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Meridian Bioscience
VIVO
|
82.4 M | - | - | $ 1.49 B | USA |
 |
Danaher Corporation
DHR
|
6.42 B | $ 181.52 | -3.27 % | $ 129 B | USA |
 |
Surmodics
SRDX
|
248 K | - | - | $ 608 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.29 | -6.54 % | $ 2.3 M | USA |